Marco Bolis
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Orphan Nuclear Receptors expression and function in breast cancer cells: oncogenic action of the NR2F6 receptor.
Journal: Cell communication and signaling : CCS
Published: December 05, 2025
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple Myeloma.
Journal: Journal of cellular and molecular medicine
Published: October 28, 2025
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules.
Journal: bioRxiv : the preprint server for biology
Published: September 15, 2025
A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.
Journal: Cancer research
Published: July 08, 2025
An integrated proteomic portrait of prostate cancer progression.
Journal: Cell reports
Published: January 27, 2025
Mesenchymal Stromal Cell Secretome and Its Key Bioactive Metabolites Induce Long-Term Neuroprotection After Traumatic Brain Injury in Mice.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 22, 2024
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.
Journal: International journal of molecular sciences
Published: November 12, 2024
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.
Journal: Cell death & disease
Published: September 18, 2024
Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.
Journal: Oncogene
Published: September 03, 2024
Last Updated: 09/26/2026